|
|
|
eBook/Digital Version available from:
|
Score: 100 |
 |
| Advancing Healthcare Through Personalized Medicine, 2nd Edition |
|
|
Doody's Core Title (2024 Edition)
|
|
| Score(s): |
|
2.5
(Health Sciences - Clinical Genetics)
|
|
|
ISBN: 978-3030800994,
745 pages,
Soft Cover
ISBN-10: 3030800997 |
|
| Copyright: |
2021 |
|
| Edition: |
2nd |
|
| Author: |
Hays, Priya |
|
|
Specialties:
|
Clinical Genetics
, General Internal Medicine |
|
| Publisher: |
Springer |
|
| List Price: |
$219.99 |
|
| Google: |
|
|
|
|
|
|
|
At A Glance
|
This book provides a unique perspective on the biomedical and societal implications of personalized medicine and how it helps to mitigate the healthcare crisis and rein in ever-growing expenditure. It introduces the reader to the underlying concepts at the heart of personalized medicine.An innovative second edition, this book functions as an update to the successful first edition to include new, state-of-the-art information and advancements in the fast-paced field of personalized medicine.Chapters examine pharmacogenomics, targeted therapies, individualized diagnosis and treatment, and cancer immunotherapies. The book also features an essential discussion on how the advent of genomic technologies gives clinicians the capability to predict and diagnose disease more efficiently and offers a detailed up-to-date compilation of clinical trials in cancer leading to breakthrough therapies. The book also addresses the impact of Big Data on personalized medicine and the newfound applications of digital health and artificial intelligence.A work that advocates for a patient-centered approach,Advancing Healthcare Through Personalized Medicine, Second Editionis an invaluable text for clinicians, healthcare providers, and patients.
|
|
Reviewer:
|
Vincent Carr,
DO, MSA, FACC, FACP
(Uniformed Services University of the Health Sciences)
|
|
|
Range
|
Question
|
Score
|
| 1-10 |
Are the author's objectives met? |
10 |
| 1-10 |
Rate the worthiness of those objectives. |
10 |
| 1-5 |
Is this written at an appropriate level? |
5 |
| 1-5 |
Is there significant duplication? (1=significant, 5=insignificant) |
5 |
| 1-5 |
Are there significant omissions? (1=significant, 5=insignificant) |
5 |
| 1-5 |
Rate the authority of the authors. |
5 |
| 1-5 |
Are there sufficient illustrations? |
5 |
| 1-5 |
Rate the pedagogic value of the illustrations. |
5 |
| 1-5 |
Rate the print quality of the illustrations. |
5 |
| 1-5 |
Are there sufficient references? |
5 |
| 1-5 |
Rate the currency of the references. |
5 |
| 1-5 |
Rate the pertinence of the references. |
5 |
| 1-5 |
Rate the helpfulness of the index. |
5 |
| 1-5 |
If important in this specialty, rate the physical appearance of the book |
N/A |
| 1-10 |
Is this a worthwhile contribution to the field? |
10 |
| 1-10 |
If this is a 2nd or later edition, is this new edition needed? |
10 |
|
|
|
Reviewer:
|
Vincent Carr,
DO, MSA, FACC, FACP
(Uniformed Services University of the Health Sciences)
|
|
|
Description
|
| This book, now in its second edition, presents the advancements of personalized medicine since the first edition was published in 2017. |
|
|
Purpose
|
| The scope of personalized medicine is ever expanding with research in many areas beyond the initial attempts of matching medication to genetics. This edition details how and in what direction personalized medicine has evolved. |
|
|
Audience
|
| This book is for everyone in the scientific community, as well as academics, laypersons, and policymakers. There are many far-reaching aspects of the science focused on individual genetics. |
|
|
Features
|
| The book has 14 chapters that cover biomedical innovation and policy in the 21st century; the rise of genomics and personalized medicine; alliances between knowledge infrastructures and the digitalization of precision health; great strides in precision medicine such as personalized oncology, immunotherapies, and molecular diagnostics; biomarkers, diagnosis, treatment, and education from the clinic to the boardroom; new sets of tools for physicians; legislation, reimbursement, and the regulatory landscape; and moral, societal, and ethical issues including claims, consequences, and caveats. Each chapter has many subchapters detailing specific aspects of personalized and precision medicine. Samples of these chapters include the Human Genome Project; Sequencing and Genomic Medicine; Implications of Precision Medicine for Patient Care and Disease Treatment; Liquid Biopsy; Type II Diabetes; Neurological Disease: Alzheimer's Disease; FDA Pharmacogenomics Drug Labeling; and Patient Preference, Right "Not to Know." The chapter on personalized oncology is greatly inclusive of many studies in breast and leukemia cancer research. Each subchapter provides a concise, yet comprehensive outline of the topic augmented by many figures and tables with extensive references. |
|
|
Assessment
|
| This second edition is an extraordinary compendium of the state of the art in personalized genomic evidence, bringing together some of the important research that is building the foundation for future standards of medical care. |
|
|
|
|
|
|
|
|
